Moreover, expression of the heparin degrading endosulfatase HSulf-1, which diminishes the sulfation of cell-surface heparan sulfate proteoglycans, was found to be downregulated in breast, renal, pancreatic, hepatic, and ovarian cancer cells compared to normal cells [24,25,40]. This evidence concerns the gene CD44 and ovarian carcinoma.